Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1

Huan He1, Dandan Song1, Indranil Sinha1

  • 1Department of Biosciences and Nutrition, Karolinska Institutet, S-141 83, Huddinge, Sweden.

Oncogene
|April 25, 2019
PubMed

Insights

The activator protein 1 (AP-1) family member Fra-1 is overexpressed in triple-negative breast cancer (TNBC). Researchers identified DDX5 as a key interacting protein, revealing DDX5 as a potential therapeutic target for TNBC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Proteomics

Background:

  • Fra-1, a member of the activator protein 1 (AP-1) family, is overexpressed in triple-negative breast cancer (TNBC).
  • Fra-1 plays crucial roles in tumor growth and progression within TNBC.
  • The precise molecular mechanisms governing Fra-1's function in TNBC are not fully elucidated.

Purpose of the Study:

  • To identify proteins interacting with endogenous chromatin-bound Fra-1 in TNBC cells.
  • To investigate the functional role of DDX5 in Fra-1 transcriptional activity and TNBC cell proliferation.
  • To evaluate DDX5 as a potential therapeutic target for TNBC.

Main Methods:

  • Proteomic analysis to identify Fra-1 interacting proteins.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) to analyze Fra-1 and DDX5 cistromes and transcriptomes.
  • Functional assays to assess the impact of DDX5 on Fra-1 activity and cell proliferation.
  • Analysis of DDX5 expression in breast cancer patient cohorts.

Main Results:

  • 118 proteins were identified interacting with Fra-1, with DDX5 being the most enriched.
  • DDX5 shows extensive overlap with Fra-1 cistrome and transcriptome, correlating with TNBC cell growth.
  • DDX5 expression enhances Fra-1 transcriptional activity and potentiates Fra-1-driven proliferation.
  • A DDX5 target gene signature predicts poor clinical outcomes in breast cancer patients.
  • DDX5 protein levels are significantly higher in triple-negative basal-like tumors compared to other subtypes.

Conclusions:

  • DDX5 is a novel regulator of Fra-1 signaling in TNBC.
  • DDX5 potentiates Fra-1-driven TNBC cell growth and proliferation.
  • DDX5 represents a promising potential therapeutic target for triple-negative breast cancer.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.6K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.8K
Transcription01:10

Transcription

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
155.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K